表紙
市場調査レポート

米国の造影剤・放射性医薬品市場

Contrast Agents and Radiopharmaceuticals | US | 2015 | Market Analysis

発行 Decision Resources Group - Medtech Solutions 商品コード 140085
出版日 ページ情報 英文 62 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
米国の造影剤・放射性医薬品市場 Contrast Agents and Radiopharmaceuticals | US | 2015 | Market Analysis
出版日: 2014年11月30日 ページ情報: 英文 62 Pages
概要

米国の造影剤・放射性医薬品市場は全体的には縮小傾向にありますが、PET/CT放射性医薬品および超音波造影剤の市場は例外的に急速な成長を遂げています。

当レポートでは、米国における造影剤および放射性医薬品市場全体、およびセグメント別市場の概要と分析、競合の分析などを提供しています。

エグゼクティブサマリー

履歴

第1章 造影剤および放射性医薬品市場

  • 市場概要
  • 市場詳細分析
  • 競争環境
  • 競争環境詳細
  • 市場シェア
  • 近年の動向

第2章 放射性医薬品市場

  • 市場概要
  • 市場詳細分析
    • SPECT市場
    • PET/CT市場
  • 競争環境
  • 競争環境詳細
  • 市場シェア

第3章 CTおよびX線造影剤市場

  • 市場概要
  • 市場詳細分析
  • 競争環境
  • 市場シェア

第4章 MRI造影剤市場

  • 市場概要
  • 市場詳細分析
  • 競争環境
  • 市場シェア

第5章 超音波造影剤市場

  • 市場概要
  • 市場詳細分析
  • 競争環境
  • 市場シェア

付録:分析手法

付録:略語・頭語集

付録:参考文献

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: RPUS50RP14

The US market for contrast agents and radiopharmaceuticals will be limited by reimbursement restrictions and lower dosing; nonetheless, growth in the large radiopharmaceutical market and favorable demographics will result in a modest expansion of the market through 2023.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for contrast agents and radiopharmaceuticals across a 10-year period.

Questions Answered in This Report:

  • New products have recently entered the contrast agent and radiopharmaceutical market in the US, with more are expected to enter before 2023.
    • How will the launch of new products influence ASPs over the forecast period
    • What strategies can existing competitors adopt to respond to heightened competitive pressure
  • Global fluctuations in the supply of Mo-99-the key isotope in the production of Tc for use in most SPECT procedures-will continue to impact the market going forward.
    • To what extent will supply limitations affect revenue growth in the US SPECT radiopharmaceutical market
    • What strategies will vendors and facilities employ in response to supply fluctuations
  • The ASP per procedure is set to decline for contrast-enhanced procedures over the forecast period.
    • What are the key factors causing this trend
    • Which markets will be most heavily affected by this decline and why
    • What role do competitive dynamics play in causing this trend How are companies reacting to this trend

Scope:

Geographies Covered: US.

Market Forecast Features: Based on primary research with industry professionals, Millennium Research Group uses its proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, ASPs, market values, and the installed base over a 10-year period (2013-2023).

Competitive Analysis: Millennium Research Group provides a detailed analysis of the competitive landscape and market shares for leading competitors.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

VERSION HISTORY

1. CONTRAST AGENT AND RADIOPHARMACEUTICAL MARKET

  • 1.1. Market Snapshot
  • 1.2. Detailed Market Analysis
  • 1.3. Competitive Snapshot
  • 1.4. Detailed Competitive Landscape
  • 1.5. Market Shares
  • 1.6. Trends and Developments

2. RADIOPHARMACEUTICAL MARKET

  • 2.1. Market Snapshot
  • 2.2. Detailed Market Analysis
    • 2.2.1. SPECT Radiopharmaceuticals
    • 2.2.2. PET Radiopharmaceuticals
  • 2.3. Competitive Snapshot
  • 2.4. Detailed Competitive Landscape
  • 2.5. Market Shares

3. CT AND X-RAY CONTRAST AGENT MARKET

  • 3.1. Market Snapshot
  • 3.2. Detailed Market Analysis
  • 3.3. Competitive Snapshot
  • 3.4. Market Shares

4. MRI CONTRAST AGENT MARKET

  • 4.1. Market Snapshot
  • 4.2. Detailed Market Analysis
  • 4.3. Competitive Snapshot
  • 4.4. Market Shares

5. ULTRASOUND CONTRAST AGENT MARKET

  • 5.1. Market Snapshot
  • 5.2. Detailed Market Analysis
  • 5.3. Competitive Snapshot
  • 5.4. Market Shares

APPENDIX: METHODOLOGY

APPENDIX: ACRONYMS AND INITIALISMS

APPENDIX: BIBLIOGRAPHY

LIST OF FIGURES AND TABLES

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

  • Figure 1: Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2013-2023
  • Table 1: Contrast Agent and Radiopharmaceutical Market Landscape, US (USD), 2014 and 2023
  • Table 2: Contrast Agent and Radiopharmaceutical Market Leaders, by Product Type and Revenue, US, 2014
  • Table 3: Companies Mentioned
  • Table 4: Factors Impacting the Contrast Agent and Radiopharmaceutical Market, by Product Type, US
  • Table 5: Recent Events in the Contrast Agent and Radiopharmaceutical Market, US
  • Table 6: Emerging Products for the Contrast Agent and Radiopharmaceutical Market, US
  • Table 7: Key Report Updates
  • Table 8: Contrast Agent and Radiopharmaceutical Procedures and Products Covered, US

VERSION HISTORY

  • Table 9: Version History

1. CONTRAST AGENT AND RADIOPHARMACEUTICAL MARKET

  • Figure 2: Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2013-2023
  • Table 10: Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2013-2023
  • Table 11: Contrast Agent and Radiopharmaceutical Market Growth, by Product Type, US, 2014-2023
  • Figure 3: Contrast Agent and Radiopharmaceutical Revenue Market Shares, US, 2014
  • Table 12: Contrast Agent and Radiopharmaceutical Revenue Market Shares, by Product Type, US, 2014
  • Table 13: Factors Impacting the Contrast Agent and Radiopharmaceutical Market, by Product Type, US
  • Table 14: Recent Events in the Contrast Agent and Radiopharmaceutical Market, US
  • Table 15: Emerging Products for the Contrast Agent and Radiopharmaceutical Market, US

2. RADIOPHARMACEUTICAL MARKET

  • Figure 4: Radiopharmaceutical Market, by Product Type, US (USD), 2013-2023
  • Table 16: Radiopharmaceutical Market, by Product Type, US (USD), 2013-2023
  • Table 17: Radiopharmaceutical Market Growth, by Product Type, US, 2014-2023
  • Table 18: Nuclear Medicine System Installed Base, by Product Type, US, 2013-2023
  • Figure 5: Radiopharmaceutical Revenue Market Shares, US, 2014
  • Table 19: Radiopharmaceutical Revenue Market Shares, by Product Type, US, 2014

3. CT AND X-RAY CONTRAST AGENT MARKET

  • Figure 6: CT and X-Ray Contrast Agent Market, by Product Type, US (USD), 2013-2023
  • Table 20: CT and X-Ray Contrast Agent Market, by Product Type, US (USD), 2013-2023
  • Table 21: CT and X-Ray Contrast Agent Market Growth, by Product Type, US, 2014-2023
  • Table 22: CT and X-Ray System Installed Base, by Product Type, US, 2013-2023
  • Figure 7: CT and X-Ray Contrast Agent Revenue Market Shares, US, 2014
  • Table 23: CT and X-Ray Contrast Agent Revenue Market Shares, US, 2014

4. MRI CONTRAST AGENT MARKET

  • Figure 8: MRI Contrast Agent Market, US (USD), 2013-2023
  • Table 24: MRI Contrast Agent Market, US (USD), 2013-2023
  • Table 25: MRI System Installed Base, US, 2013-2023
  • Figure 9: MRI Contrast Agent Revenue Market Shares, US, 2014
  • Table 26: MRI Contrast Agent Revenue Market Shares, US, 2014

5. ULTRASOUND CONTRAST AGENT MARKET

  • Figure 10: Ultrasound Contrast Agent Market, US (USD), 2013-2023
  • Table 27: Ultrasound Contrast Agent Market, US (USD), 2013-2023
  • Figure 11: Ultrasound Contrast Agent Revenue Market Shares, US, 2014
  • Table 28: Ultrasound Contrast Agent Revenue Market Shares, US, 2014

APPENDIX: METHODOLOGY

APPENDIX: ACRONYMS AND INITIALISMS

  • Table 29: Acronyms and Initialisms

APPENDIX: BIBLIOGRAPHY

Back to Top